Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

2020 Medicare Part B premiums, Part A deductibles will rise

Medicare Part B premiums will be higher in 2020 than in 2019, while deductibles in Part A, which typically doesn’t have a premium, will also rise, according to CMS.

Thumbnail

AI in Healthcare 2020 Leadership Survey Report: About the Survey

Sponsored by Pure Storage

The AI in Healthcare team embarked on this survey to gain a deeper understanding of the current state of artificial and augmented intelligence in use and being planned across healthcare in the next few years. Read more

Thumbnail

Nala launches Arabic AI platform for healthcare, raises $1M in funding

Nala, a Riyadh, Saudi Arabia-based digital health company, has launched a new AI platform for medical diagnosis. According to Nala, it is the first platform to provide users with diagnoses in Arabic.

Thumbnail

Vaping more harmful to heart health than regular cigarettes

E-cigarette use, or vaping, could be more harmful to heart health than traditional cigarettes.

Thumbnail

KKR proposes plan to buy Walgreens in $70B deal

Private equity group KKR has offered a $70 billion buyout proposal to Walgreens Boots Alliance, the Financial Times reported.

Thumbnail

Kaiser Permanente CEO and chairman dies

Bernard Tyson, CEO and chairman of California-based not-for-profit health system Kaiser Permanente, died unexpectedly Nov. 10 at age 60.

Thumbnail

AI in Healthcare 2020 Leadership Survey Report: 7 Key Findings

Sponsored by Pure Storage

Artificial and augmented intelligence are already helping healthcare improve clinically, operationally and financially—and there is extraordinary room for growth. Success starts with leadership, vision and investment and leaders tell us they have all of the above. Read more

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup